News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Daily News CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults Michael O'Riordan December 28, 2022
News Daily News ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA Todd Neale December 16, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says L.A. McKeown December 14, 2022
News Daily News Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines L.A. McKeown December 12, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News Meth-Related HF: Challenges at the Intersection of CVD and Addiction Caitlin E. Cox December 06, 2022
News Daily News Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks L.A. McKeown November 30, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest Todd Neale November 29, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Daily News Age-Related Macular Degeneration Linked to Severe Vascular Disease Caitlin E. Cox November 18, 2022
News Daily News AHA Statement Stresses Importance of Telehealth in CVD Care Yael L. Maxwell November 16, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Conference News AHA 2022 Sizeable Minority of Pregnant Women Have CVD, US Data Show Caitlin E. Cox November 11, 2022
News Conference News AHA 2022 China Rural Intervention Still Reaping BP Control Wins at 3 Years L.A. McKeown November 09, 2022
News Conference News AHA 2022 EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD Todd Neale November 06, 2022
News Conference News AHA 2022 ‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE Michael O'Riordan November 06, 2022